Search Result

No matches for "

56156

" within the MedChemExpress (MCE) catalog. Here are the results you might be looking for.

By Targets:	c-Met/HGFR (1) Calcium Channel (1) Glycosidase (2) LPL Receptor (1) MicroRNA (16) Reference Standards (1)
By Research Areas:	Cancer (17) Cardiovascular Disease (2) Endocrinology (2) Neurological Disease (2)
Oligonucleotides:	miRNA mimics (4) miRNA agomirs (4) miRNA antagomirs (4) MicroRNAs (16) miRNA inhibitors (4)

Inhibitors & Agonists

Antibodies

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-19736

TY-52156 10+ Cited Publications	LPL Receptor	Cardiovascular Disease
TY-52156 is a potent and selective S1P₃ receptor antagonist with a K_i value of 110 nM .

HY-104038

Pariceract LTI-291; BIA 28-6156	Glycosidase	Neurological Disease Endocrinology
Pariceract (LTI-291) is an activator of glucocerebrosidase (Gcase), with activation rates of more than 60% (1 μM) and between 10%-20% (0.1 μM). Pariceract can be used for Parkinson's disease and endometriosis research .

HY-153227

SU 5616	c-Met/HGFR	Cancer
SU 5616 is an organic compound. SU 5616 potentially modulates tyrosine kinase signal transduction, and regulates abnormal cell proliferation .

HY-101707

UK51656	Calcium Channel	Cardiovascular Disease
UK51656 is a calcium antagonist with IC₅₀ of 4 nM.

HY-R03298

*mmu-miR-5615-3p mimic*	MicroRNA	Cancer
mmu-miR-5615-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-miR-5615-3p mimic mmu-miR-5615-3p mimic

HY-R03299

*mmu-miR-5615-5p mimic*	MicroRNA	Cancer
mmu-miR-5615-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-miR-5615-5p mimic mmu-miR-5615-5p mimic

HY-R03301

*mmu-miR-5616-5p mimic*	MicroRNA	Cancer
mmu-miR-5616-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-miR-5616-5p mimic mmu-miR-5616-5p mimic

HY-R03300

*mmu-miR-5616-3p mimic*	MicroRNA	Cancer
mmu-miR-5616-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

mmu-miR-5616-3p mimic mmu-miR-5616-3p mimic

HY-RI03300

*mmu-miR-5616-3p inhibitor*	MicroRNA	Cancer
mmu-miR-5616-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-5616-3p inhibitor mmu-miR-5616-3p inhibitor

HY-RI03301A

*mmu-miR-5616-5p antagomir*	MicroRNA	Cancer
mmu-miR-5616-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-5616-5p antagomir mmu-miR-5616-5p antagomir

HY-R03300A

*mmu-miR-5616-3p agomir*	MicroRNA	Cancer
mmu-miR-5616-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-5616-3p agomir mmu-miR-5616-3p agomir

HY-RI03299

*mmu-miR-5615-5p inhibitor*	MicroRNA	Cancer
mmu-miR-5615-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-5615-5p inhibitor mmu-miR-5615-5p inhibitor

HY-R03298A

*mmu-miR-5615-3p agomir*	MicroRNA	Cancer
mmu-miR-5615-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-5615-3p agomir mmu-miR-5615-3p agomir

HY-R03299A

*mmu-miR-5615-5p agomir*	MicroRNA	Cancer
mmu-miR-5615-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-5615-5p agomir mmu-miR-5615-5p agomir

HY-RI03298A

*mmu-miR-5615-3p antagomir*	MicroRNA	Cancer
mmu-miR-5615-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-5615-3p antagomir mmu-miR-5615-3p antagomir

HY-RI03301

*mmu-miR-5616-5p inhibitor*	MicroRNA	Cancer
mmu-miR-5616-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-5616-5p inhibitor mmu-miR-5616-5p inhibitor

HY-RI03298

*mmu-miR-5615-3p inhibitor*	MicroRNA	Cancer
mmu-miR-5615-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-5615-3p inhibitor mmu-miR-5615-3p inhibitor

HY-RI03299A

*mmu-miR-5615-5p antagomir*	MicroRNA	Cancer
mmu-miR-5615-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-5615-5p antagomir mmu-miR-5615-5p antagomir

HY-RI03300A

*mmu-miR-5616-3p antagomir*	MicroRNA	Cancer
mmu-miR-5616-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-5616-3p antagomir mmu-miR-5616-3p antagomir

HY-R03301A

*mmu-miR-5616-5p agomir*	MicroRNA	Cancer
mmu-miR-5616-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

mmu-miR-5616-5p agomir mmu-miR-5616-5p agomir

HY-104038R

Pariceract (Standard) LTI-291 (Standard); BIA 28-6156 (Standard)	Reference Standards Glycosidase	Neurological Disease Endocrinology
Pariceract (Standard) is the analytical standard of Pariceract (HY-104038). This product is intended for research and analytical applications. Pariceract (LTI-291) is an activator of glucocerebrosidase (Gcase), with activation rates of more than 60% (1 μM) and between 10%-20% (0.1 μM). Pariceract can be used for Parkinson's disease and endometriosis research .

Host:	Mouse (4) Rabbit (1)
Reactivity:	Human (5) Rat (2) Mouse (3)
Application:	IHC-P (4) ICC/IF (4) IP (1) WB (5) ELISA (4)
Isotype:	IgG (1) IgG2a (1) IgG2b (2)
Conjugation:	Non-conjugated (5)
Clonality:	Monoclonal (5)
Modification:	Unmodified (5)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P85464

	RASSF1 Antibody (YA5156) RASSF1; RDA32; Ras association domain-containing protein 1	WB	Human
	RASSF1 Antibody (YA5156) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to RASSF1.

HY-P86464

	CD21 Antibody (YA6156) CR2; C3DR; Complement receptor type 2; Cr2; Complement C3d receptor; Epstein-Barr virus receptor; EBV receptor; CD21	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	CD21 Antibody (YA6156) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CD21.

HY-P85924

	p57 Kip2 Antibody (YA5616) Beckwith Wiedemann syndrome; BWCR; BWS; CDKI; CDKN 1C; CDKN1C; CDN1C_HUMAN; Cyclin dependent kinase inhibitor 1C; Cyclin dependent kinase inhibitor p57; Cyclin-dependent kinase inhibitor 1C; Cyclin-dependent kinase inhibitor p57; KIP 2; KIP2; p57; p57 Kip 2; p57KIP2; WBS	IHC-P, WB, ICC/IF, ELISA	Human, Mouse, Rat
	p57 Kip2 Antibody (YA5616) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to p57 Kip2.

HY-P85964

	p57 Kip2 Antibody (YA5656) Beckwith Wiedemann syndrome; BWCR; BWS; CDKI; CDKN 1C; CDKN1C; CDN1C_HUMAN; Cyclin dependent kinase inhibitor 1C; Cyclin dependent kinase inhibitor p57; Cyclin-dependent kinase inhibitor 1C; Cyclin-dependent kinase inhibitor p57; KIP 2; KIP2; p57; p57 Kip 2; p57KIP2; WBS	IHC-P, WB, ICC/IF, ELISA	Human
	p57 Kip2 Antibody (YA5656) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to p57 Kip2.

HY-P85923

	Oct-2 Antibody (YA5615) class 2; Lymphoid restricted immunoglobulin octamer binding protein; Lymphoid-restricted immunoglobulin octamer-binding protein NF-A2; NF A2; Oct 2; Oct-2; Octamer binding transcription factor 2; Octamer-binding protein 2; Octamer-binding transcription factor 2; OTF-2; OTF2; PO2F2_HUMAN; POU domain; POU domain class 2 transcription factor 2; POU2F2; transcription factor 2	IHC-P, WB, ICC/IF, ELISA	Human, Mouse
	Oct-2 Antibody (YA5615) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to Oct-2.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name		Classification

HY-R03298

*mmu-miR-5615-3p mimic*		MicroRNAs miRNA mimics
mmu-miR-5615-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R03299

*mmu-miR-5615-5p mimic*		MicroRNAs miRNA mimics
mmu-miR-5615-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R03301

*mmu-miR-5616-5p mimic*		MicroRNAs miRNA mimics
mmu-miR-5616-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-R03300

*mmu-miR-5616-3p mimic*		MicroRNAs miRNA mimics
mmu-miR-5616-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

HY-RI03300

*mmu-miR-5616-3p inhibitor*		MicroRNAs miRNA inhibitors
mmu-miR-5616-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI03301A

*mmu-miR-5616-5p antagomir*		MicroRNAs miRNA antagomirs
mmu-miR-5616-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R03300A

*mmu-miR-5616-3p agomir*		MicroRNAs miRNA agomirs
mmu-miR-5616-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI03299

*mmu-miR-5615-5p inhibitor*		MicroRNAs miRNA inhibitors
mmu-miR-5615-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-R03298A

*mmu-miR-5615-3p agomir*		MicroRNAs miRNA agomirs
mmu-miR-5615-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R03299A

*mmu-miR-5615-5p agomir*		MicroRNAs miRNA agomirs
mmu-miR-5615-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI03298A

*mmu-miR-5615-3p antagomir*		MicroRNAs miRNA antagomirs
mmu-miR-5615-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI03301

*mmu-miR-5616-5p inhibitor*		MicroRNAs miRNA inhibitors
mmu-miR-5616-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI03298

*mmu-miR-5615-3p inhibitor*		MicroRNAs miRNA inhibitors
mmu-miR-5615-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

HY-RI03299A

*mmu-miR-5615-5p antagomir*		MicroRNAs miRNA antagomirs
mmu-miR-5615-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-RI03300A

*mmu-miR-5616-3p antagomir*		MicroRNAs miRNA antagomirs
mmu-miR-5616-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

HY-R03301A

*mmu-miR-5616-5p agomir*		MicroRNAs miRNA agomirs
mmu-miR-5616-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

Inquiry Online

Submit your filled information, we will contact you soon.

Salutation:		* Country or Region:
* Applicant Name:		* Organization Name:
* Department:
* Email Address:		* Product Name:
Cat. No.:		* Requested quantity:
* Phone Number:
MCE Japan Authorized Agent:	ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Remarks:

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: